Skip to main content
OpenTrials

Clinical trial condition

Blood Coagulation Disorders, Inherited

Explore clinical trials studying Blood Coagulation Disorders, Inherited. Study availability and eligibility vary by location and protocol.

852 public trials 115 recruiting studies
Refine in advanced search Browse all conditions

Blood Coagulation Disorders, Inherited trial results

Recruiting

A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A

NCT07416604

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Center for Inherited Blood Disorders Orange, California, United States
  • Innovative Hematology, Inc. Indianapolis, Indiana, United States
  • University Of Iowa Hospitals And Clinics Iowa City, Iowa, United States
  • Washington Center for Bleeding Disorders Seattle, Washington, United States
View Trial Details
Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A

NCT05987449

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • UC Davis Cancer Center Sacramento, California, United States
  • Georgetown Uni Medical Center Washington D.C., District of Columbia, United States
  • Indiana Hemophilia & Thrombosis center Indianapolis, Indiana, United States
  • University of Iowa Hospitals and Clnics Dept of Pediatrics Iowa City, Iowa, United States
View all 14 locations
View Trial Details
Recruiting

Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) as Prophylactic Treatment.

NCT07684898

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin, Tianjin Municipality, China
  • Fuyang Hospital, Affiliated to Anhui Medical University Fuyang, China
  • Fujian Medical University Union Hospital Fuzhou, China
  • Nanfang Hospital of Southern Medical University Guangzhou, China
View all 19 locations
View Trial Details
Recruiting

A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)

NCT06349473

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +10 more
Locations
  • California Clinical Trials Medical Group (CCTMG) Glendale, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • LA Center for Bleeding and Clotting Disorders - Metairie Metairie, Louisiana, United States
View Trial Details
Recruiting

Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis

NCT05022459

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Stanford University Palo Alto, California, United States
  • Rady Children's Hospital San Diego, California, United States
  • Johns Hopkins All Children's Hospital St. Petersburg, Florida, United States
View Trial Details
Recruiting

A Study Assessing HMB-002 in Participants With Von Willebrand Disease

NCT06754852

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Platelet Disorders, +12 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • University of Miami Hospital and Clinics, Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 25 locations
View Trial Details
Recruiting

Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog Alfa

NCT06940830

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Sobi Investigational Site Zagreb, Croatia
  • Sobi Investigational Site Brno, Czechia
  • Sobi Investigational Site Ostrava, Czechia
  • Sobi Investigational Site Prague, Czechia
View all 29 locations
View Trial Details
Recruiting

Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa

NCT06716814

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +16 more
Locations
  • Sobi Investigational Site Plovdiv, Bulgaria
  • Sobi Investigational Site Sofia, Bulgaria
  • Sobi Investigational Site Brest, France
  • Sobi Investigational Site Bron, France
View all 21 locations
View Trial Details
Recruiting

A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B

NCT07285460

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • The Luskin Orthopaedic Institute for Children- Site Number : 8400013 Los Angeles, California, United States
  • The Center for Inherited Blood Disorders- Site Number : 8400009 Orange, California, United States
  • Cure 4 The Kids Foundation- Site Number : 8400001 Las Vegas, Nevada, United States
  • Hackensack Meridian Health - Hackensack University Medical Center- Site Number : 8400008 Hackensack, New Jersey, United States
View all 30 locations
View Trial Details

Related conditions